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The multiple transferable resistance (MTR) pump, from
Neisseria gonorrhoeae, is typical of the specialized machinery
used to translocate drugs across the inner and outer mem-
branes of Gram-negative bacteria. It consists of a tripartite
complex composed of an inner-membrane transporter, MtrD,
a periplasmic membrane fusion protein, MtrC, and an outer-
membrane channel, MtrE. We have expressed the components
of the pump in Escherichia coli and used the antibiotic vanco-
mycin, which is too large to cross the outer-membrane by pas-
sive diffusion, to test for opening of the MtrE channel. Cells
expressing MtrCDE are not susceptible to vancomycin, indi-
cating that the channel is closed; but become susceptible to
vancomycin in the presence of transported substrates, consis-
tent with drug-induced opening of the MtrE channel. A muta-
tional analysis identified residues Asn-198, Glu-434, and Gln-
441, lining an intraprotomer groove on the surface of MtrE, to
be important for pump function; mutation of these residues
yielded cells that were sensitive to vancomycin. Pull-down as-
says and micro-calorimetry measurements indicated that this
functional impairment is not due to the inability of MtrC to
interact with the MtrE mutants; nor was it due to the MtrE
mutants adopting an open conformation, because cells ex-
pressing these MtrE mutants alone are relatively insensitive to
vancomycin. However, cells expressing the MtrE mutants with
MtrC are sensitive to vancomycin, indicating that residues lin-
ing the intra-protomer groove control opening of the MtrE
channel in response to binding of MtrC.
Gram-negative bacteria frequently utilize transport systems
composed of a tripartite assembly of proteins that span both
the inner and outer membranes to pump antibiotics from the
cell. These assemblies consist of an inner-membrane protein
(IMP),3 which transduces electrochemical energy, and an
outer-membrane protein (OMP) that are connected by a
periplasmic membrane fusion protein (MFP), which is an-
chored to the inner membrane (1–3). The systems largely uti-
lize proton-antiporters but there are some that utilize ABC
transporters (4–5). Analogous tripartite pumps exist that ex-
port proteins such as toxins and adhesion factors, and for
such pumps the IMP is typically an ABC transporter (6). In-
deed, the importance of such systems is emphasized by the
fact that the same OMP can be utilized for both drug and
toxin extrusion: for example, TolC functions with antibiotic
H-antiporters, such as AcrB that belongs to the RND family
(7–8), with ABC transporters, such as the macrolide trans-
porter MacB (4), and with HlyB that extrudes the protein-
toxin -hemolysin (6).
Although the structures of representatives of all the indi-
vidual components have been elucidated, the structure of an
assembled tripartite complex has not yet been determined. A
well studied example for which the structures are known for
all the constituent components is the AcrABTolC multidrug-
pump from Escherichia coli; for which the structure of the
RND transporter AcrB (9–10) and of its cognate MFP, AcrA
(11), and OMP, TolC (12), have been determined. Cross-link-
ing studies (13) indicate that the six -hairpins from the up-
per headpiece of the AcrB-trimer contact the tips of the six
helical pairs of the TolC trimer (14), forming a continuous
path across the periplasm. Because of this internal pseudo
6-fold symmetry in both OMP and IMP, the exact stoichiom-
etry of the MFP binding is still strongly debated with 3:3:3
(15) and 3:6:3 (16) being the most popular candidates. The
latter suggests that there are both intra-protomer and inter-
protomer grooves on the surface of the OMP that can accom-
modate the MFP. Modeling studies, supported by cross-link-
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ing, suggest that the coiled-coil domain of AcrA can fit into
the intra-protomer grooves of the open state of TolC, to make
contacts that resemble helical bundles, with corresponding
contacts between the -/lipoyl-domains of AcrA and the
periplasmic domain of AcrB (15, 17, 18). There are several
lines of evidence to suggest that assembly of the tripartite
complex is a dynamic process in which the protein compo-
nents undergo conformational changes. In most of the avail-
able structures of OMPs the channel is closed at one or both
sides, so that conformational changes are required to allow
passage of the substrate (14, 15, 17, 19). It is conceivable that a
small number of key interactions between adjacent coiled-
coils of the OMP are broken to allow the inner coils to un-
twist and realign with the outer coils, increasing the aperture
of the OMP entrance (14, 20–22). Interaction with AcrA may
enable the realignment of the coiled-coils, resulting in stabili-
zation of TolC in the open state (11, 14, 20). Recent crystallo-
graphic studies of AcrB indicate that it can adopt at least
three different conformations, lending support to a mechanis-
tic model in which there is a functional rotation in the
periplasmic domains driving transfer of drugs into the OMP
(23–26). These conformational changes in AcrB could be
transmitted to TolC via AcrA (14).
We have sought to further investigate the assembly of a
tripartite multidrug efflux pump using as a model the
MtrCDE-system from Neisseria gonorrhoeae, which is respon-
sible for the extrusion of antibiotics, including -lactams and
macrolides, and hydrophobic agents, such as detergents and
antimicrobial peptides (27–29). This efflux pump is an impor-
tant contributor in conferring resistance to antibiotics and,
because of its ability to extrude antimicrobial oligopeptides,
such as PC-8 and LL-37, produced by mammalian cells as part
of their innate defense, contributes to the virulence of the
human pathogens N. gonorrhoeae and N. menigitidis (30–35).
This system has the advantage that all the components of the
pump are encoded by the same operon and, consequently, the
interactions between the components are likely to be specific,
facilitating analyses of pump assembly. We present evidence
for a model for the transport mechanism in which drug bind-
ing to the IMP MtrD, an RND transporter, induces a tight
interaction of the coiled-coil hairpin domain of the MFP
MtrC with an intra-protomer groove on the surface of the
OMPMtrE, to induce the open state necessary for drug efflux.
EXPERIMENTAL PROCEDURES
Strains and Plasmids—The E. coli strains and plasmids
used are described in supplemental Table S1, and the primers
used for construction of plasmid vectors in supplemental Ta-
ble S2. ThemtrC,mtrD, andmtrE genes were amplified from
the genomic DNA of N. gonorrhoeae FA19 (36).
Site-directed Mutagenesis of mtrE—Site-directed mutagene-
sis was performed with the QuickChange XL kit (Stratagene).
For in vivo functional analyses of the pump the pACYCDuet-
mtrC/mtrD/mtrE plasmid was used as the template; while for
the purification of MtrE derivatives, the pET-mtrE plasmid
was used as the template; with the primers given in supple-
mental Table S3 used to introduce the required mutations
intomtrE. PCR reactions were performed using the following
cycling parameters: initial activation 95 °C-1 min, denatur-
ation 95 °C-50 s, annealing 55 °C-50 s, and extension 68 °C-10
min for 17 cycles, with a final extension at 68 °C for 10 min.
After PCR, the template was digested with Dpn1 for 3 h and 5
l of the PCR mix was transformed into Novoblue E. coli and
colonies were selected for chloramphenicol resistance. Plas-
mids were extracted from the colonies and their DNA
sequenced.
Protein Overexpression and Purification—All the proteins
used in this study were purified as fusion proteins with a six-
histidine tag. The E. coli cells harboring plasmids were grown
at 37 °C in 2xYT media, with shaking at 220 rpm. When the
cell density reached an A600 of 0.6, 0.5 mM IPTG was added,
the temperature was adjusted to 25 °C and cells left to overex-
press proteins for 6 h for membrane proteins and 3 h for solu-
ble proteins. Cells were harvested by centrifugation at 4 °C
and resuspended in 20 mM Tris-HCl buffer, 300 mM NaCl, pH
7.5, 10% v/v glycerol. Cell paste was supplemented with com-
plete protease inhibitor (Roche) and DNase I (Sigma) prior to
lysis using three passes through a cell disrupter (1 10 kpsi
and 2 25 kpsi, model Z-plus 1.1kW, Constant Systems).
Cell debris were removed by centrifugation at 37,000 g (45
min at 4 °C), and cell membranes isolated by ultracentrifuga-
tion at 125,000 g (90 min at 4 °C) for membrane proteins,
while the supernatant was collected for soluble proteins.
Membranes pellets were then solubilized in 20 mM Tris-HCl
buffer, pH 7.5, 100 mM NaCl, 10% (v/v) glycerol, 2% w/v
DDM.
MtrD Purification—Membranes pellets were dissolved in
2% w/v DDM and MtrD protein was purified under 0.1% w/v
DDM by affinity chromatography using a Ni2-charged
HiTrap chelating column (GE Healthcare). After desalting,
MtrD samples were subjected to ion exchange chromatogra-
phy, using a HiTrap Q column (GE Healthcare) and eluted
using a NaCl gradient.
1–34-MtrC Purification—NT-MtrC supernatant was pu-
rified by affinity chromatography using a HiTrap Ni2-chelat-
ing column, followed by gel filtration chromatography with
buffer 20 mM Tris-HCl buffer, pH 7.5, 300 mM NaCl, 10% v/v
glycerol.
MtrE Purification—MtrE was purified as described for the
purification of MtrD but was subject to cation exchange chro-
matography using a HiTrap SP column (GE Healthcare) after
the chelating column step.
MtrC Hairpin Purification—MtrC -helical hairpin was
purified as described for the purification of NT-MtrC.
Growth Curve Analyses—E. coli cells, of strain (acrB)
KAM3(DE3)(37) or (tolC) TG1(DE3) (38), harboring plas-
mids were grown at 37 °C (200 rpm) until the cell density
reached an A600 of 0.5, and then induced with1 mM IPTG.
The cells were grown for a further 3 h, diluted with 2xYT me-
dia containing antibiotic and the growth curve recorded; or
the cells monitored for growth after 24 h for MIC
measurements.
Microcalorimetry—ITC measurements were carried out at
25 °C using a VP-ITC Micro-Calorimeter (MicroCal). MtrD
and MtrE were prepared in 20 mM Tris-HCl, pH 7.5, 300 mM
NaCl, 10% (v/v) glycerol, 0.1% w/v DDM (buffer 1). After
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adding DDM to NT-MtrC and MtrC hairpin to a final con-
centration of 0.1% (w/v), they were dialyzed in different dialy-
sis cassettes at the same time with MtrD or MtrE against
buffer 1. An ITC experiment involved making a single 2 l
and a series of 8 l injections of protein into the instrument
mixing chamber, which contained the other protein. All data
were corrected for the heat changes arising from injection of
proteins into buffer before data analysis with ORIGIN soft-
ware (MicroCal). Experiments were carried out in triplicate
and a statistical average taken.
Pulldown Assays—For pulldown assays, proteins were over-
expressed with a C-terminal S-tag or GST-tag for use with the
cognate protein that was His-tagged. Membrane pellets, con-
taining the S-tagged or GST-tagged prey protein, were solubi-
lized in 2% w/v DDM and mixed with purified His-tagged
bait-protein (2 mg in 1 ml). The mixture was loaded onto a
Ni2-charged Hitrap chelating column (GE Healthcare), so
that the bait-protein could be immobilized on the column
along with the prey protein if they interact. The column was
then washed with 20 column volumes of Tris buffer contain-
ing 25 mM imidazole and 0.1% w/v DDM to eliminate any
nonspecific interactions. The bait-prey protein complex was
eluted with 500 mM imidazole Tris buffer, containing 0.1%
w/v DDM, and SDS-PAGE used to visualize the bait and
prey proteins. A Western blot was performed with anti-S tag
or anti-GST tag antibodies to confirm the presence of the S-
tagged and GST-tagged prey proteins. For the MtrE E434K
pulldown assay, the purified NTMtrC GST-tagged protein
was used as bait, immobilized on GST column beads (GE
Healthcare), to which was added purified His-tagged MtrE
E434K prey protein (5 mg protein in 0.5 ml). The beads
were washed with Tris buffer, containing 0.1% w/v DDM,
and finally the beads were boiled at 90 °C for 5 min to elute
the complex. Western blotting was performed with both anti-
GST and anti-His tag antibodies to detect bait and prey pro-
teins, respectively.
Disc Diffusion Assays—E. coli cells were grown to an A600 of
about 0.5, induced with 0.5 mM IPTG, the cells were diluted
to 0.1 and then 200 l of cell culture were spread on an MHA
plate previously incorporated with 0.5 mM IPTG; antibiotic
discs were placed on the plate medium and incubated at 37 °C
overnight. The zone of culture growth inhibition was deter-
mined. The discs used were impregnated with 1 g/ml nafcil-
lin, 30 g/ml tetracycline, 10 g/ml erythromycin, 5 g/ml
novobiocin, and 30 g/ml vancomycin.
Mass Spectrometry—Analyses were performed in a nano-
flow electro-spray mass spectrometer (nES-MS) QSTAR and
Q-ToF-2 (Waters, Milford, MA). The following experimental
parameters were used on QSTAR to record mass spectra of 16
mg/ml MtrE: capillary voltage up to 1.2 kV, declustering po-
tential 150 V, focusing potential 150 V, de-clustering poten-
tial-2 15 V, and collision energy up to 70 V. In MS mode, the
following QToF-2 parameters were used for analysis of MtrE:
capillary voltage 1668 V, sample cone 150 V, extractor cone 0
V, accelerating voltage into the collision cell (termed “colli-
sion energy” as per the manufacturer’s terminology) 150 V,
ion transfer stage pressure 6.1 103 mbar and ToF analyzer
pressure 1.0 104 mbar.
Molecular Modeling—Because of the low sequence identity
between MtrE and OMPs of known structure, combined se-
quence and structural alignments were created using T-coffee
(39) and Expresso3D (40), respectively, and manually ana-
lyzed, followed by homology model building with Modeler
(41), using the TolC (1ek9.pdb, 2vde.pdb) and OprM
(1wp1.pdb) structures as templates. Because of the higher
level of sequence identity (43%) and homology (75%) as calcu-
lated using the Smith-Waterman sequence similarity algo-
rithm (42), we have used OprM as a guidance for the manual
refinement of the MtrE model using geometrical (Ramachan-
dran and torsion) restraints in Coot (43). The helical regions
of OprM share sufficient homology with MtrE to allow the
unambiguous assignment of the periplasmic part of the pro-
tein (see structural alignment of MtrE and OprM provided in
supplemental Fig. S1). The optimized model was stereo-
chemically consistent as witnessed by a Ramachandran plot
analysis (performed with RAMPAGE, Ref. 44) with 96.6% of
the residues in favored regions, 2.7% in allowed and only 0.7%
outliers, as well as a ProSa model quality Z-score of7.01
(45).
RESULTS
MtrC Interacts with MtrD and MtrE—Interactions between
N. gonorrhoeaeMtrC, MtrD, and MtrE were tested for using
detergent-solubilized proteins for pulldown assays (Fig. 1).
One protein was expressed as a fusion protein with a His tag,
which was used to purify the protein on an IMAC column,
over which was passed a complex mixture of detergent-solu-
bilized membrane proteins that included the cognate protein
with an S tag. Interacting proteins were tested for by Western
blotting using an antibody to the S tag. Using this approach
MtrC was found to interact with MtrD (Fig. 1A) and MtrE
(Fig. 1B). Although we detected an interaction between MtrD
and MtrE (Fig. 1C), the intensity of the band suggested a weak
interaction. The fact that in each case the cognate pump pro-
tein could be pulled-out of a complex mixture of detergent-
solubilized proteins from membranes or cells indicated that
the interactions are specific.
Microcalorimetry was used to assess the affinities of these
interactions. When NT-MtrC was titrated into MtrE a weak
exothermic interaction, with a Kd of 9.8 (4.9) M, was de-
tected (Fig. 2A), which was characterized by a change in en-
thalpy (H) of6.8 (3.58) kcalmol1 and entropy (S) of
0.01 calmol1K1. In contrast, when NT-MtrC was ti-
trated into MtrD, a strong endothermic reaction, with a Kd of
0.8 (0.70) M, was detected (Fig. 2B), which was character-
ized by a H of 1.4 (0.32) kcalmol1 and S of 32.5
calmol1K1. In accord with our pulldown experiments that
suggested that MtrD interacts weakly with MtrE, no apprecia-
ble interaction was detected by ITC (Fig. 2C). Our ITC mea-
surements indicated that MtrE and MtrD have similar affini-
ties for MtrC to that of TolC and AcrB for AcrA (7). In each
case it is notable that the OMP binds the MFP with an affinity
that is about an order-of-magnitude less than the IMP binds
the MFP. In the case of TolC and AcrA this might have arisen
because TolC needs to interact with a number of different
transport systems. However, our studies established MtrC
Characterization ofMtrCDE Tripartite Pump
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binds MtrE with a lower affinity than MtrD, suggesting that
this is an intrinsic feature of such pumps, which might reflect
a need to load and unload the OMP.
MtrC Interacts with MtrD and Mtr Eto Form a Functional
Multidrug Pump—To establish that the MtrCDE proteins
formed a functional multidrug pump we expressed them in
the E. coli acrB strain KAM3 (37) and a tolC TG1 strain
(38) that are hypersensitive to antibiotics; revealing that while
MtrD alone did not confer resistance, it was able to confer
resistance when expressed with MtrC and E (Table 1).
We used the antibiotic vancomycin, which is too large
(1450 Da) to cross the outer-membrane by passive diffusion
(14), to test for opening of MtrE, which would allow its pas-
sage into the cells to disrupt peptidoglycan synthesis. In com-
parison to control tolC TG1 cells, transformed with pACYC,
cells transformed with pACYC-mtrCDE were equally insensi-
tive to vancomycin; but only the latter became highly suscep-
tible to vancomycin in the presence of nafcillin (Table 2). For
example, while both tolC TG1 control cells, transformed
with pACYC, and cells expressing MtrCDE, transformed with
pACYC-mtrCDE, both had an MIC for vancomycin of 512
g/ml; in the presence of (1 g/ml) nafcillin this had reduced
to 128 g/ml and 8 g/ml for control and MtrCDE-express-
ing cells, respectively. Although the data for the control cells
suggest nafcillin and vancomycin can act synergistically, pre-
sumably to do so the vancomycin must gain entry to the cells.
Our data for cells expressing MtrCDE suggest that there is a
more substantive uptake of vancomycin by these cells than
control cells. Similarly, KAM3 cells expressing MtrCDE were
more susceptible to vancomycin in the presence, than the
absence, of nafcillin (supplemental Fig. S2). We also tested the
effect of tetracycline on the susceptibility of the tolC TG1
cells expressing MtrCDE to vancomycin: revealing an appar-
ent sensitivity of the cells to vancomycin in the presence of
tetracycline (supplemental Fig. S3). That this effect is small
might be due to the ability of the pump to remove vancomy-
cin from the cells, so that while some vancomycin leaks into
the cells, some is pumped out again. It is notable that cells
expressing MtrCDE tend to grow better than control cells,
lacking the pump, in the presence of vancomycin. In any
event, our data clearly indicate that the MtrCDE channel is
effectively closed (to vancomycin) in the absence of trans-
ported drugs and suggests that MtrD, upon drug binding, in-
duces conformational changes in MtrC that enable it to inter-
act with MtrE to induce opening of its channel (allowing
vancomycin entry).
Residues Within the Intra-protomer Groove of the MtrE tri-
mer Are Important for the Function of the Assembled Tripar-
tite Pump—Previous studies of the interaction of AcrA with
TolC indicate that the hairpin domain of the MFP binds
within an intra-protomer groove, bounded by helices 3, 7, and
8, of the OMP (15). To pinpoint the possible MtrC-interact-
ing residues on the surface of MtrE, we have created a homol-
ogy model of the MtrE (Fig. 3 and supplemental Fig. S4B)
based upon the available three-dimensional structures of
OMPs. To experimentally test that MtrE has the same oligo-
meric state as that of other OMPs already crystallized, we
used mass spectrometry (46) to determine the molecular
weight of the intact assembly; which indicated a trimeric stoi-
chiometry with a molecular mass of 148,890 (32) Da (sup-
plemental Fig. S4A).
A comparative analysis of the modeled MtrE and TolC
molecules was performed with a view to identifying conserved
solvent accessible residues, and taking into account previous
mutagenesis data (14, 15, 21). Based on this analysis, three
point mutants (e.g. E434K, Q441E, and N198L), positioned
toward the proximal, middle, and distal end of the intra-pro-
tomer groove, were constructed, along with mutants (e.g.
R239E and K397E) located outside the intra-protomer groove
as a control, and the effects of these in respect to their antibiotic
sensitivity were tested. In contrast to the cells expressing
MtrCD with the R239E and K397E derivatives of MtrE, those
expressing the N198L, E434K, and Q441E derivatives clearly
had an increased sensitivity (as indicated by lower MICs) to a
range of antibiotics (Table 2). Surprisingly, when we com-
pared the growth curves for these MtrE derivatives, we found
that mutations in the intra-protomer groove had a marked
effect, with these mutants being even more susceptible to an-
tibiotics than control cells lacking a drug pump (Fig. 4). This
FIGURE 1. The interaction of MtrC, MtrD, andMtrE. The pulldown of MtrC
by MtrD and MtrE: purified His-tagged MtrD (A) and MtrE (B) were used as
bait, immobilized on a Ni2-agarose column, over which a slurry of deter-
gent-solubilized membranes, from strains overexpressing S-tagged MtrC,
was passed to test whether the MtrC protein could be pulled-out of this
complex mixture of proteins. The MtrC prey protein was detected by West-
ern blotting, using antibodies to the S tag. The pulldown of MtrE by MtrD:
purified His-tagged MtrD (C) was used as bait, immobilized on a Ni2-aga-
rose column, over which a slurry of detergent-solubilized membranes, from
strains overexpressing S-tagged MtrE, was passed to test whether this pro-
tein could be pulled-out of this complex mixture of proteins. The MtrE prey
protein was detected by Western blotting, using antibodies to the S tag. As
negative controls, either the bait protein or the prey protein was omitted
from the assay (the presence and absence of proteins is indicated by
and). As shown in each assay when either of these proteins was omitted
from the assay, the corresponding prey protein could not be detected. As a
positive control for the presence of the bait protein in each assay, the His-
tagged protein was detected by Western blotting, using antibodies to the
His-tag. In pulldown assays both the His-tagged bait and S-tagged prey
proteins were detected. These assays indicate that MtrC interacts with MtrD
and MtrE and that there is a weak interaction between MtrD and MtrE.
Characterization ofMtrCDE Tripartite Pump
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behavior was apparent for both nafcillin, which targets peni-
cillin-binding proteins in the periplasm, and tetracycline,
which targets the ribosome in the cytoplasm. Consequently,
this data would argue against these mutations simply disrupt-
ing the interaction of MtrCD with MtrE but suggests that the
pump assembles and that this is detrimental to the growth of
the cells.
We also analyzed the effects of antibiotics, including vanco-
mycin, on the growth of these mutants on plates, confirming
that the MtrE N198L, E434K, and Q441E mutants were sus-
ceptible to antibiotics and more so than the R239E and K397E
mutants (Table 3). Importantly, these studies revealed more
pronounced differences between the mutants: cells expressing
MtrCD, with wild-type MtrE or its R239E and K397E deriva-
tives, were insensitive to vancomycin; while the growth of the
E434K and Q441E mutants was completely inhibited by van-
comycin (Table 3). These data strongly suggest that the im-
paired function of the N198L, E434K and Q441E mutants is
due to the pump becoming leaky, which would also explain
why its assembly is detrimental to the cells.
Residues in the Intra-protomer Groove of MtrE Influence
Opening of the Channel—Because mutation of the intra-
protomer groove impaired pump function, we tested
whether this arose due to a reduced interaction of MtrC
with the MtrE derivatives. A pulldown experiment was un-
dertaken using GST-tagged NT MtrC as the bait and His-
tagged MtrE E434K as the prey; revealing that the interac-
tion was not compromised and that MtrC was capable of
pulling-down MtrE E434K (Fig. 5). In comparison to the
wild-type MtrE control, we did not see any reduction in the
intensity of the band corresponding to His-tagged MtrE
E434K on a Western blot, suggesting that MtrE and its
E434K derivative have at least similar affinities for MtrC.
Furthermore, we sought to test if the MtrE E434K deriva-
tive interacted with the coiled-coil hairpin domain of
MtrC. For this experiment, we made a construct to express
the hairpin domain of MtrC, consisting of residues 103–
183; the purified protein had a CD spectrum that indicated
that it retained -helical structure (data not shown). Using
ITC, we established that the hairpin binds to both wild-
type MtrE and its E434K derivative (Fig. 6). Analysis of the
binding isotherms indicated that the hairpin binds to a site
on MtrE that is characterized by a Kd, H and S
of 2.2(0.29) M, 11 (13.1) kcalmol1 and 11.6
calmol1K1; while its binding to the E434K derivative
was characterized by a Kd, H and S of 0.13 (0.078)M,
4.1 (0.31) kcalmol1 and 17.8 calmol1K1. Interest-
ingly, these data indicate that MtrE E434K binds the hair-
pin of MtrC with an affinity that is one-to-two orders of
magnitude greater than the wild-type protein binds the
FIGURE 2. ITC analyses of the interaction of MtrC, MtrD, andMtrE. 200 M NT-MtrC was titrated into (A) 15 M MtrE and (B) 12 M MtrD; and in (C) 15 M
MtrE was titrated into 12 M MtrD in a VP-ITC microcalorimeter and the heat exchange determined at 25 °C. In each case, the upper panel shows the raw
energy changes during the titration, while the lower panel represents the derived integrated total energy change as a function of the molar ratio (based on
the molecular weight of the monomeric protein) of the interactants. Non-linear regression fitting of the data (shown as a solid line through the data points
in the lower panel) to a monophasic one-site model yielded the following thermodynamic parameters for the interaction: the interaction of Nt-MtrC with
MtrE was characterized by a Ka, H and S of 1.0 (0.50) 10
5
M
1,6836 (3575) calmol1 and0.01 calmol1K1; while the interaction of Nt-MtrC
with MtrD was characterized by a Ka, H, and S of 1.2 (1.0) 10
6
M
1, 1412 (318) calmol1 and 32.5 calmol1K1.
TABLE 1
MICs for (acrB)KAM3(DE3) and (tolC)TG1(DE3) strains expressing
mtr genes
Strain/constructs Penicillin G Nafcillin Tetracycline Erythromycin
g/ml g/ml g/ml g/ml
KAM3/pACYC 32 32 4 0.5
KAM3/pACYCMtrD 32 32 16 2
KAM3/pACYCMtrCDE 64 1024 64 128
TG1/pACYC vector 16 1.5625 0.5 2
TG1/pACYCMtrD 16 1.5625 0.5 2
TG1/pACYCMtrCDE 64 32 12.5 64
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hairpin or NT MtrC (see 0.13 M versus 2.2/9.8 M), sug-
gesting that this derivative forms a tight assembly with
MtrCD.
One possibility is that MtrC traps MtrE E434K in the open
conformation, so that it becomes leaky. Consequently, we
sought to determine if the mutations in the intra-protomer
groove of MtrE had caused the channel to become leaky, by
testing the susceptibility of cells expressing these MtrE mu-
tants with MtrCD to vancomycin. These studies revealed that
all of the intra-protomer groove mutants were susceptible to
vancomycin, while the R239E and K397E derivatives of MtrE
were relatively insensitive to vancomycin (Fig. 7 and Table 3).
This behavior cannot be attributed to a decrease in the ex-
pression of the MtrE derivatives because this would be ex-
pected to decrease, not increase, the susceptibility of the cells
to vancomycin. Furthermore, purification of the MtrE E434K
derivative indicated that it was expressed and targeted to the
membrane at similar levels to wild-type MtrE, while our pull-
down studies confirmed that it was equally capable of forming
a complex with MtrC as wild-type MtrE (Fig. 5).
Although the above data suggest that the MtrE N198L,
E434K, and Q441E mutants, when expressed with MtrCD,
become leaky to vancomycin, presumably because of opening
of the MtrE channel, it was not clear if this arose due to an
intrinsic leakiness of the MtrE mutants. To determine if these
MtrE mutants were intrinsically leaky, and to avoid any po-
tential interaction with AcrAB, they were expressed alone in
KAM3 cells, showing that none of them were as sensitive to
vancomycin as when expressed with MtrCD (Table 3). This
suggests that the interaction of the MtrE derivatives with
MtrC, and possibly MtrD, is needed to stabilize the open con-
formation of MtrE. However, expression of MtrC with these
MtrE mutants conferred sensitivity to vancomycin to the
cells, indicating that they only required an interaction with
MtrC to become leaky (Table 3). This contrasts with cells ex-
pressing wild-type MtrCE and MtrCDE, which are relatively
insensitive to vancomycin (Table 3), suggesting that the inter-
action with drug-loaded MtrD is required to fully unlock the
channel for the wild-type MtrCDE assembly.
DISCUSSION
Recent studies suggest that the MFP plays more than a pas-
sive role in coupling the IMP and OMP: in that it interacts
with and induces opening of the OMP channel. For example,
in one study, the TolC K383E and AcrA D149K mutants were
shown to be individually hypersensitive to novobiocin but,
when expressed together, complemented one another to con-
fer resistance to novobiocin (14). This suggests that there is a
direct interaction of TolC and AcrA involving these residues,
possibly via the formation of a salt bridge. Furthermore, in
contrast to mutations in the TolC channel, which conferred
vancomycin sensitivity on the mutant cells, the TolC K383E
mutant was relatively insensitive to vancomycin, and it was
concluded that the K383E derivative was probably impaired in
its ability to interact with AcrA. In another study, four resi-
dues, 147GLVA150, located in the turn region between the
outer helices H3 and H4 of TolC, were simultaneously altered
to 147AGSG150; the resulting mutant was hypersensitive to
several antibiotics, but insensitive to vancomycin (47). Be-
cause this mutant interacted with AcrA, its impaired function
was attributed to closure of the TolC channel. The character-
ization of antibiotic-resistant revertants of cells expressing
TolC 147AGSG150 with AcrAB revealed compensatory
changes in AcrA; suggesting that these induced or stabilized
an opening of the TolC channel. Although these studies indi-
cate that AcrA can support the open state of TolC, its exact
role in regulating the transition of TolC from its closed to
open state remains unclear as in these studies TolC was mu-
tated so that the channel was either open (14) or closed (47).
For example, in the first study a salt bridge in the channel of
TolC was disrupted, by introducing a Y362F/R367E double
mutation, to make it leaky (14); while in the other study the
periplasmic end of TolC, comprising of residues 147–150, was
TABLE 2
MICs determined by broth-dilution method formtrEmutants expressed withmtrCD in E.coli (tolC) TG1(DE3)
MtrE intra-protomer groove mutants (N198L, E434K and Q441E) are shown in bold; underline indicates faint growth; antibiotic abbreviations are Pen, penicillin G;
Naf, nafcillin; Tet, tetracycline; Ery, erythromycin; Nov, novobiocin; and Van, vancomycin; and for studies of the simultaneous effects of nafcillin and vancomycin, the
MIC for vancomycin was determined in the presence of 1 g/ml nafcillin.
Constructs Pen Naf Tet Ery Nov Van Van ( 1 g/ml Naf)
g/ml g/ml g/ml g/ml g/ml g/ml g/ml
Vector pACYC 16 1.5625 0.5 2 0.5 512 128
MtrE WT-CD 64 32 12.5 64 2 512 8
MtrE N198L-CD 32 8 <0.5 2 1 256 8
MtrE Q441E-CD 16 1 <0.5 64 <0.5 64 8
MtrE E434K-CD 16 1 <0.5 64 <0.5 64 8
MtrE R239K-CD 64 32 12.5 0.5 2 256 8
MtrE K397E-CD 64 32 12.5 0.5 2 256 8
FIGURE 3. Amolecular homologymodel of the structure of MtrE show-
ing the intra-protomer grooves and the position of themutations in-
troduced into the intra-protomer groove and the flanking region.
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mutated from GLVA to AGSG, causing it to close (47). In ad-
dition to these studies, two mutants of TolC, R367H, and
R390C, have been reported that cause TolC to adopt a consti-
tutively open state (14, 20, 48).
We have sought to investigate the potential role of the MFP
in inducing opening of the OMP channel using the compo-
nents of the MtrCDE multidrug pump from N. gonorrhoeae.
The introduction of N198L, E434K, and Q441E mutations,
positioned toward the proximal, middle, and distal end of the
intra-protomer groove of MtrE, all impaired pump function,
so that the cells expressing themtrEmutants withmtrCD
became hypersensitive to a range of antibiotics (Fig. 4 and
Table 2). Surprisingly, an analysis of the growth curves of the
E434K and Q441E mutants revealed that they were more sus-
ceptible to nafcillin and tetracycline than control cells (Fig. 4),
suggesting that for these mutants assembly of the pump was
detrimental for the cells. Consistent with this suggestion, the
E434K and Q441E mutants grew poorly in the presence of
vancomycin (Fig. 7), indicating that they form a leaky pump.
However, although the E434K and Q441E mutants were sen-
sitive to vancomycin, this did not prevent their growth (Fig.
7). Furthermore, MIC measurements indicated that neither
mutant was hypersensitive to vancomycin but that they be-
came highly susceptible to it in the presence of nafcillin (Ta-
FIGURE 4.Mutations in the intra-protomer groove of MtrE impair the MtrCDE pump. Growth curves for a tolC TG1(DE3) strain expressing themtrCDE
genes, in the presence of (A) 16 g/ml nafcillin and (B) 3 g/ml tetracycline, for wild-typemtrE and a series ofmtrEmutants, and the same strain trans-
formed with the empty vector as control. The growth curve corresponding to each mutant, the WT and control are indicated to the right of each curve.
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ble 2). These data indicate that, although leaky, these mutants
are able to undergo the transition from the closed to open
state in response to transported drugs. It is worth noting that
Glu-434 occupies a position corresponding to Lys-383 in
TolC, the exact residue, which has been shown to be directly
involved in an interaction with AcrA (14) and thus it is plausi-
ble that it is also directly involved in the interaction with the
MFP MtrC in the MtrCDE system, as it appears to be exposed
on the surface as well.
Taken together, these data suggest that the intra-protomer
groove of MtrE has a role in controlling the closed to open
transition and mutations in the groove can induce the open
state. However, it is possible that this behavior could arise
because the MtrE mutant is unable to interact with MtrC.
Consequently, we performed a pulldown assay, which re-
vealed that MtrC interacts with MtrE E434K as strongly as
with wild-type MtrE (Fig. 5). Considering this, we tested the
vancomycin sensitivity of cells expressing the E434K and
Q441E derivatives in the absence and presence of MtrC.
These studies revealed that while the cells expressing E434K
and Q441E were insenstive to vancomycin, those co-express-
ing these mutants in conjunction with MtrC were hypersensi-
tive to vancomycin (Table 3). These data suggest that al-
though mutation of the intra-protomer groove may facilitate
opening of the channel, the interaction with MtrC is required
for this to occur. Interestingly, while cells expressing MtrE
E434K with MtrC did not grow at all on vancomycin plates,
those expressing MtrE E434K with MtrCD grew, albeit poorly
(Table 3). In comparison, cells expressing wild-type MtrCE
had a slight sensitivity to vancomycin, again suggesting that
the MFP unlocks the channel. In contrast, cells expressing
MtrCDE appeared to be sensitive to vancomycin only in the
presence of transported substrates (Tables 2 and 3). These
findings suggest that in the fully assembled transporter, MtrC
is blocked from opening the MtrE channel, which is otherwise
locked, until induced to do so by MtrD as it binds drugs.
FIGURE 5. Analysis of the interaction of the MtrC with MtrE E434K.
Purified GST-tagged NT-MtrC protein was used as bait, immobilized on
GST column beads, to which was added purified His-tagged MtrE E434K
prey protein. The beads were washed with Tris buffer, containing 0.1%
w/v DDM, and finally the beads were boiled at 90 °C for 5 min to elute
the complex. This experiment was repeated using purified His-tagged
wild-type MtrE as a positive control. The following samples were run on
an SDS-PAGE gel: wild-type MtrE (lane 1), MtrE E434K input control (lane
2), NT-MtrC GST input control (lane 3), GST tag input control (lane 4), NT
MtrC-GST wild-type MtrE pulldown (lane 5), NT-MtrC-GST MtrE
E434K pulldown (lane 6), MW marker (lane 7), GST tag wild-type MtrE
pulldown control (lane 8), and GST tag MtrE E434K pulldown control
(lane 9). The MtrC bait protein and the MtrE prey protein were detected
by Western blotting using antibodies to the GST tag and the His tag
(lower and upper panel), respectively. In pulldown assays both the His-
tagged prey- and GST-tagged bait proteins were detected, indicating
that NT-MtrC interacts with the MtrE E434K derivative.
TABLE 3
The inhibitory zone determined by the disc diffusion method formtrEmutants expressed with or withoutmtrC ormtrCD in E.coli (tolC)
TG1(DE3) and (acrB) KAM3(DE3) cells
The inhibitory zone diameter is given in mm; abbreviations are NI, no inhibition of growth; NG, no growth due to complete growth inhibition; Naf, nafcillin; Tet,
tetracycline; Ery, erythromycin; Nov, novobiocin; and Van, vancomycin. The MtrE derivatives with intra-protomer groove mutations are shown in bold.
Strain/constructs Naf (1 g/ml) Tet (30 g/ml) Ery (10 g/ml) Nov (5 g/ml) Van (30 g/ml)
TG1/pACYC 20 35 31 27 NI
TG1/MtrE WT-CD 12 25 20 19 NI
TG1/MtrE N198L-CD 20 33 31 27 7
TG1/MtrE E434K-CD 25 40 33 28 NG
TG1/MtrE Q441E-CD 19 40 33 27 NG
TG1/MtrE R239E-CD 14 29 27 25 NI
TG1/MtrE K397E-CD 14 29 29 21 NI
KAM3/pET21a 7 30 26 20 NI
KAM3/MtrE WT NI 26 21 15 NI
KAM3/MtrE N198L NI 26 21 15 NI
KAM3/MtrE E434K NI 26 21 15 NI
KAM3/MtrE Q441E NI 26 21 15 NI
KAM3/MtrE R239E NI 26 21 15 NI
KAM3/MtrE K397E NI 26 21 15 NI
KAM3 pACYC 7 36 31 17 NI
KAM3/MtrE WT-C 24 36 37 21 9
KAM3/MtrE N198L-C NI 26 21 15 NI
KAM3/MtrE E434K-C NG 50 40 NG NG
KAM3/MtrE Q441E-C NG 36 37 21 27
KAM3/MtrE E434K-CD 20 46 40 19 20
KAM3/MtrE WT-CD NI 27 21 10 NI
Characterization ofMtrCDE Tripartite Pump
FEBRUARY 18, 2011•VOLUME 286•NUMBER 7 JOURNAL OF BIOLOGICAL CHEMISTRY 5491
 at DURHAM









Previous studies have been interpreted in terms of a trans-
port mechanism in which there are two energetically distinct
steps (14). Firstly, the helical protrusions of the OMP engage
in the exposed periplasmic crown of the IMP, regardless of
the drug-bound state, resulting in a partial opening of the
OMP channel. Consistent with this proposal, our studies con-
firm that there is a weak interaction of MtrD and MtrE in the
absence of drugs (Fig. 1C). Upon opening of the periplasmic
gates of the OMP, as a result of the interaction between the
crown of the IMP and the tip of the periplasmic end of the
OMP (13), helices H7/H8 of the OMP partially relax and an
intra-protomer groove is exposed in the OMP, which forms
part of the binding site for the MFP. In the resting state, this
groove is less pronounced, and the MFP cannot be accommo-
dated (7). Although our studies indicate that MtrC binds to
the intra-protomer groove, formed by helices H7/H8, of MtrE
(Fig. 4) even in the absence of MtrD (Fig. 1B), the interaction
is weaker than that of MtrD with MtrC (Fig. 2A). The engage-
ment of the MFP with the intra-protomer groove of the OMP,
which is in the partially opened state, is thought to be neces-
sary to force further opening of the channel. Consistent with
this proposal, when MtrE is expressed with MtrC the channel
becomes slightly leaky to vancomycin (Table 3). This behavior
is more pronounced for the MtrE E434K mutant, which is
insensitive to vancomycin but becomes very leaky to vanco-
mycin when expressed with MtrC (Table 3 and Fig. 7). It is
thus possible to suggest a role for the Glu-434 in not-so-much
docking of the MFP, but in transmitting the opening signal
after the initial dock takes place, possibly by interacting with
the second selectivity gate in the OMP (14) and facilitating its
unlocking. On the other hand, in the fully assembled tripartite
complex, composed of the wild-type proteins, drug binding to
MtrD is apparently required before MtrC can unlock the
FIGURE 6. ITC analysis of the interaction of the MtrC hairpin with MtrE and its E434K. 500 MMtrC hairpin was titrated into (A) 15 MMtrE and (B) 15
M) MtrE E434K in a VP-ITC micro-calorimeter and the heat exchange determined at 25 °C. The upper panel shows the raw energy changes during the titra-
tion, while the lower panel represents the derived integrated total energy change as a function of the molar ratio (based on the molecular weight of the
monomeric protein) of the interactant. In the case of wild-type MtrE, for which the titration was extended to a molar ratio of 2.5, the data were best-fitted to




(0.96) 103 M1,1.2 (1.31) 104 calmol1,6.2 (0.01) 104 calmol1,11.4 calmol1K1, and190 calmol1K1, respectively. In the case of
the MtrE E434K derivative, the titration was restricted to a molar ratio of 1.5, and consequently it was only appropriate to fit the data to a one site model;
the high-affinity site was characterized by a Ka, H and S of 8.2 (4.8) 10
6
M
1,4115 (311) calmol1 and 17.8 calmol1K1.
FIGURE 7.Mutation of the intra-protomer groove induces opening of
the MtrE channel in the MtrCDE pump. A bar chart showing the 4-h
growth for a tolC TG1(DE3) strain expressing themtrCDE genes in the pres-
ence of 160 g/ml vancomycin, for wild-typemtrE and a series ofmtrEmu-
tants (as indicated), and the same strain transformed with the empty vector
as control. Cells expressing MtrCDE, MtrCD, and the R239E and K397E deriv-
atives of MtrE, as well as the control cells, were insensitive to vancomycin;
while cells expressing MtrCD and the N198L, E434K, and Q441E derivatives
of MtrE, which are located in the intra-protomer groove, were clearly sus-
ceptible to vancomycin.
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outer gate of MtrE (Table 3). The MtrE E434K derivative
likely corresponds to a conformation that is primed for open-
ing upon interaction with MtrC; and as such, may resemble
the conformation of wild-type MtrE bound to the MtrD/drug
complex. In this conformation of MtrE, presumably the outer
gate is locked and the intra-protomer groove is exposed ready
for the high affinity binding of the MFP, which would be nec-
essary to unlock the outer gate and stabilize the open state.
Considering that the MtrE E434K derivative does not allow
the passage of vancomycin (Table 3) is consistent with the
outer gate being locked in this conformational state and that
binding of MtrC is required to induce unlocking of this gate.
Furthermore, the E434K derivative binds the hairpin domain
of MtrC with high affinity (Fig. 5), similar to that between
MtrC and MtrD (Fig. 2B), consistent with a state in which the
MFP becomes buried, and bound tightly, within the intra-
protomer groove.
In summary, the MtrCDE proteins form a functional tripar-
tite efflux-pump, similar to the AcrABTolC pump, in which
the IMP drives a conformational switch that affects both the
destabilization of the OMP gates and the presentation of an
intra-protomer groove, to which the MFP binds and becomes
buried, transferring the energy provided by the IMP, via sev-
eral key residues that communicate with residues lining the
OMP channel, to drive its full opening.
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